By Andrea Hargraves 
Private clinics in São Paulo plan to start by the end of March flu In 2022. Some units are already scheduling the start of the home application from 25. In the public network, the campaign usually begins in April, but the Ministry of Health is studying to anticipate. The new immunity was adapted to the Darwinian strain of the virus, which caused an outbreak of cases in Brazil at the end of last year.
In a note, the ministry stated that it has already contracted 80 million doses of vaccines from the Butantan Institute. Ten days ago, the São Paulo agency expected to deliver the first batch of influenza (influenza) vaccinations this year, with two million doses.
Public network vaccination aims to immunize the most vulnerable groups, including the elderly over 60 years of age, children under 6 years of age, pregnant women, postpartum women, people with comorbidities, indigenous peoples, health and education professionals, among others. . About 70% of deaths from the disease fall into these groups.
The national campaign will include 80 million doses, half of which will be delivered by the end of March. According to Putantan, the rest are due to be delivered by the end of April. As the immune system of the new strain is updated, doctors recommend even those who received the vaccine at the end of 2021 to look for a health center or clinic.
Vaccin Clinic already sends patient information to schedule home appointments. Applications will start from March 25th. For upfront payment, the cost of a dose is R$100. After the vaccine arrives, the order cost should be between R$130 and R$160.
Dasa, an integrated health network of more than 900 units across Brazil, plans to start the campaign against influenza this year between March and April. Once it starts, the interested party can move on to the unit or schedule a home order.
The CBD also intends to start a flu vaccination campaign between the end of March and the beginning of April. According to the laboratory, it will be possible to schedule the application for home, as well as to attend the unit on Avenida Brasil, in Jardim Paulista, in the southern region of the capital of São Paulo – with or without prior appointment.
Grupo Fleury informs that it will get the updated version of the Darwin breed inclusion, but it still doesn’t have an exact date to start offering the service.
“Influenza causes annual outbreaks that peak in the fall and winter, causing 1,000 to 3,000 deaths and about 6,000 cases of severe acute respiratory syndrome (SARS), one of the dangerous forms that also manifests itself,” Isabella Balalai says. in covid-19. Vice President of the Brazilian Society of Immunization (SBIm).
Last year, the flu vaccination campaign started in April and lasted until September due to low adherence. The balance was 72.1% of the target audience vaccinated, but the federal government’s goal was for 90% of the priority group to be vaccinated.
Also according to the Ministry of Health, vaccines against covid-19 can be given concurrently with other vaccinations or at any time in the population over 12 years old. Children ages 5 to 11 must wait 15 days between the coronavirus vaccine and other immunizations.
Butantan is already testing a unique device against influenza and virus
The Putantan Institute reported last week that it had obtained promising results in the initial tests of a single vaccine against influenza and the Covid-19 virus. According to the São Paulo Agency, tests conducted on animal models showed the production of antibodies induced by the immune system against the three strains of influenza (H1N1, H3N2 and B) and against the novel coronavirus.
Butantan believes clinical trials in humans can begin in up to one year. This step is critical to verify the safety and efficacy of the product.
According to the institute, a new vaccine project, conducted by Brazilian scientists in partnership with international bodies, has the potential to make it cheaper and increase the capacity to produce vaccines for Brazil and other developing countries.
The American laboratory Novavax is also looking for a unique immune system. Human trials began in September in Australia, following promising results from preclinical trials, according to the drug company. Data from the new testing phase is expected to be released this semester. The US company Moderna is another company that has already announced plans to release a single vaccine in 2023.